Advertisement
Screener

CARDLYTICS, INC. (CDLX) Cash and Cash Equivalents, Fair Value Disclosure

2.0 / 5 stars · 29/73 Roast Me

CARDLYTICS, INC. Cash and Cash Equivalents, Fair Value Disclosure

CARDLYTICS, INC. (CDLX) had Cash and Cash Equivalents, Fair Value Disclosure of $26.28 million as of 2025-12-31, per its 10-Q filed 2026-08-05.

Financial Statements › Notes › Fair Value Disclosures

us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-08-05

  • 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure $26.28M.
Period endCash and Cash Equivalents, Fair Value Disclosure
2025-12-31$26.28M
10-Q · filed 2026-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM)United States$0.016B-4.22
Global Interactive Technologies, Inc. (GITS)$0.008B
TaoWeave, Inc. (TWAV)United States$0.006B
ZW Data Action Technologies Inc. (CNET)$0.005B-5.46
AIRWA INC. (YYAI)United States$0.004B-101.45
Teads Holding Co. (TEAD)United States$0.045B-0.14
Professional Diversity Network, Inc. (IPDN)United States$0.060B
PodcastOne, Inc. (PODC)United States$0.068B-42.98
Eva Live Inc (GOAI)United States$0.083B
Health Catalyst, Inc. (HCAT)United States$0.132B-0.56